TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $78,157 | -70.2% | 4,975 | -68.8% | 0.00% | -100.0% |
Q1 2023 | $262,658 | +10.4% | 15,938 | -13.3% | 0.00% | – |
Q3 2022 | $238,000 | -68.4% | 18,386 | -65.8% | 0.00% | -100.0% |
Q2 2022 | $754,000 | +135.6% | 53,732 | +140.6% | 0.00% | – |
Q1 2022 | $320,000 | -55.2% | 22,329 | -43.1% | 0.00% | -100.0% |
Q4 2020 | $714,000 | +82.6% | 39,227 | +104.3% | 0.00% | -75.0% |
Q1 2019 | $391,000 | – | 19,202 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |